As raw material and energy prices rise, so do Coloplast's costs
In Tuesday’s Q1 financial results, medtech company Coloplast’s top and bottom lines reported growth, but increasing energy expenses and wage inflation in Hungary have meant that production costs have also gone up during the first quarter.
by CHRISTOPHER DUE KARLSSON, translated by daniel pedersen
It is not only Coloplast’s top and bottom lines that have taken leaps in the first quarter of the skewed financial year 2021/2022.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Coloplast upgrades growth expectations following acquisition
For subscribers
.jpg&w=384&q=75)
